Related Experiment Videos
Pyruvate dehydrogenase deficiency in a child responsive to thiamine treatment
O Pastoris1, S Savasta, P Foppa
1Institute of Pharmacology, Science Faculty, University of Pavia, Italy.
Insights
Pyruvate dehydrogenase deficiency in a child was treated with thiamine, reversing symptoms and normalizing blood acids. Discontinuing thiamine caused symptoms to return, highlighting its crucial role.
Area of Science:
- Biochemistry
- Pediatrics
- Neurology
Background:
- Pyruvate dehydrogenase deficiency is a rare metabolic disorder affecting energy production.
- Investigated for a suspected metabolic disorder, a 4-year-old child presented with specific clinical features.
Observation:
- A muscle biopsy was performed, and the obtained data suggested thiamine treatment.
- The child received thiamine supplementation, leading to clinical improvement.
Findings:
- Treatment with thiamine resulted in a regression of clinical findings.
- Blood lactic and pyruvic acid levels returned to normal following thiamine administration.
- Interruption of thiamine supplementation led to a prompt recurrence of clinical and biochemical symptoms.
Implications:
- Thiamine is a crucial therapeutic agent for pyruvate dehydrogenase deficiency.
- This case underscores the importance of identifying and treating metabolic disorders promptly.
- Early diagnosis and management can significantly improve patient outcomes in pyruvate dehydrogenase deficiency.
Abstract:
We report the clinical features in a 4-year-old child who was investigated for a suspected metabolic disorder but was subsequently diagnosed as having a pyruvate dehydrogenase deficiency. A muscle biopsy was performed and the data obtained suggested thiamine treatment which resulted in a regression of the clinical findings and a return to normal values of blood lactic and pyruvic acids. The interruption of thiamine supplementation after 1 year of treatment led to a prompt recurrence of the previous clinical and biochemical symptoms.